Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods

Contemporary Clinical Trials(2022)10.1016/j.cct.2022.106909Source: DataRank Database

A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods is a research paper published in Contemporary Clinical Trials (2022). On theSindex it has a DataRank of 0. It has been cited 13 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access13 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 2.24)OA: greenTopics (32)IDs (PubMed, PMC, OpenAlex)Annotations (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Franziska Plessow ORCID,Liya Kerem ORCID,Elisa Asanza,Michelle L. O’Donoghue ORCID,Fatima Cody Stanford ORCID

Live enrichment

PubMed:36087842 PMC:PMC10329413 OpenAlex:https://openalex.org/W4294904689

NIDDK NIH HHS

Grant: R01 DK109932

NIDDK NIH HHS

Grant: P30 DK046200

NIMH NIH HHS

Grant: K24 MH120568

NIDDK NIH HHS

Grant: P30 DK040561

NIDDK NIH HHS

Grant: P30 DK135043

FWCI

2.24

Citation Percentile

0.9%

Citation Trend

2023

2024

2025

2026

greenLicense: http://www.elsevier.com/open-access/userlicense/1.0/

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10329413/pdf/nihms-1903909.pdf

publisherhttps://api.elsevier.com/content/article/PII:S155171442200235X?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S155171442200235X?httpAccept=text/plain

repositoryhttps://www.ncbi.nlm.nih.gov/pmc/articles/10329413

Fields of Study

Neuroendocrine regulation and behaviorMaternal Mental Health During Pregnancy and PostpartumRegulation of Appetite and Obesity

MeSH Terms

Administration, IntranasalAdultAnimalsDouble-Blind MethodFemaleHumansMaleMiddle AgedObesityOxytocinWeight LossRandomized Controlled Trials as TopicTreatment Outcome

Keywords

MedicineTolerabilityClinical endpointPlaceboOxytocinRandomized controlled trialAdverse effectWeight lossNasal administrationRandomizationObesityInternal medicinePharmacologyEnergy metabolismNeuroimagingAppetite Regulation

A randomized, double-blind, placebo-controlled clinical trial of 8-week intranasal oxytocin administration in adults with obesity: Rationale, study design, and methods

FAIR Checklist

Authors (16)

Funding (5 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)